Trial · NCT01078389
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Score of the Single Affected Joint | Febuxostat 40 mg or 80 mg | Baseline | 0.16 | Standard Deviation 0.444 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Score of the Single Affected Joint | Placebo | Baseline | 0.11 | Standard Deviation 0.438 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Score of the Single Affected Joint | Febuxostat 40 mg or 80 mg | Change from Baseline at Month 24 | 0.01 | Standard Deviation 0.330 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Score of the Single Affected Joint | Placebo | Change from Baseline at Month 24 | 0.01 | Standard Deviation 0.248 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Total Scores From Full Hands and Feet Radiographs | Febuxostat 40 mg or 80 mg | Baseline | 4.98 | Standard Deviation 9.707 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Total Scores From Full Hands and Feet Radiographs | Placebo | Baseline | 4.56 | Standard Deviation 8.631 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Total Scores From Full Hands and Feet Radiographs | Febuxostat 40 mg or 80 mg | Change from Baseline at Month 24 (n=78,74) | 0.31 | Standard Deviation 2.447 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Total Scores From Full Hands and Feet Radiographs | Placebo | Change from Baseline at Month 24 (n=78,74) | 0.29 | Standard Deviation 1.746 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Scores From Full Hands and Feet Radiographs | Febuxostat 40 mg or 80 mg | Baseline | 0.36 | Standard Deviation 1.160 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Scores From Full Hands and Feet Radiographs | Placebo | Baseline | 0.17 | Standard Deviation 0.473 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Scores From Full Hands and Feet Radiographs | Febuxostat 40 mg or 80 mg | Change from Baseline at Month 24 (n=78,74) | 0.17 | Standard Deviation 1.709 | score on a scale |
| Mean Change From Baseline to Month 24 in the Modified Sharp/Van Der Heijde Erosion Scores From Full Hands and Feet Radiographs | Placebo | Change from Baseline at Month 24 (n=78,74) | 0.11 | Standard Deviation 0.969 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Febuxostat 40 mg or 80 mg | Synovitis:Baseline (BL)(n=82,76) | 1.29 | Standard Deviation 0.782 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Placebo | Synovitis:Baseline (BL)(n=82,76) | 1.09 | Standard Deviation 0.687 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Febuxostat 40 mg or 80 mg | Synovitis:Change from Baseline (n=75,67) | -0.43 | Standard Deviation 0.713 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Placebo | Synovitis:Change from Baseline (n=75,67) | -0.07 | Standard Deviation 0.531 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Febuxostat 40 mg or 80 mg | Erosion (Distal+Proximal):Baseline (n=84,77) | 1.63 | Standard Deviation 0.935 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Placebo | Erosion (Distal+Proximal):Baseline (n=84,77) | 1.48 | Standard Deviation 0.916 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Febuxostat 40 mg or 80 mg | Erosion (Distal+Proximal):Change from BL(n=79,69) | -0.01 | Standard Deviation 0.702 | score on a scale |
| Mean Change From Baseline to Month 24 in the Rheumatoid Arthritis MRI Scoring System (RAMRIS) Score of the Single Affected Joint | Placebo | Erosion (Distal+Proximal):Change from BL(n=79,69) | 0.04 | Standard Deviation 0.475 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01078389/results